Detalhe da pesquisa
1.
Incidence of infusion reactions to intravenous golimumab: results from a prospective, real-world community registry.
Clin Exp Rheumatol
; 38(2): 371, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31820720
2.
Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics.
J Am Acad Dermatol
; 71(4): 649-55, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24974240
3.
Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics.
J Am Acad Dermatol
; 69(5): 729-735, 2013 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23981683
4.
Real-World Retention and Clinical Effectiveness of Secukinumab for Axial Spondyloarthritis: Results From the Canadian Spondyloarthritis Research Network.
J Rheumatol
; 50(5): 634-640, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36642434
5.
Real-World Retention and Clinical Effectiveness of Secukinumab for Psoriatic Arthritis: Results From the Canadian Spondyloarthritis Research Network.
J Rheumatol
; 50(5): 641-648, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36521913
6.
Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study.
Arthritis Care Res (Hoboken)
; 75(2): 240-251, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35678771
7.
Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.
J Rheumatol
; 50(3): 426-432, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36319003
8.
Canadian Adalimumab Postmarketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (COMPLETE-PsA): 12-month Results of Comparative Effectiveness of Adalimumab and nbDMARDs.
J Rheumatol
; 49(5): 454-464, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35033999
9.
A Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab Biosimilar.
Adv Ther
; 39(1): 44-57, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34757601
10.
Canadian Rheumatology Association Living Guidelines for the Pharmacological Management of Rheumatoid Arthritis With Disease-Modifying Antirheumatic Drugs.
J Rheumatol
; 49(10): 1092-1099, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35840155
11.
Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry.
BMJ Open
; 10(8): e036245, 2020 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32792436
12.
Comparative overview of safety of the biologics in rheumatoid arthritis.
J Rheumatol Suppl
; 82: 25-32, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19509327
13.
Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J
; 17(1): 64, 2019 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31500631
14.
Real-world utilization of methotrexate or prednisone co-therapy with etanercept among Canadian patients with rheumatoid arthritis: a retrospective cohort study.
Curr Med Res Opin
; 35(11): 2025-2033, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31237785
15.
Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study.
Ther Adv Musculoskelet Dis
; 11: 1759720X19831151, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30858896
16.
Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study.
Rheumatol Ther
; 5(2): 551-565, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30370468
17.
Long-term etanercept retention patterns and factors associated with treatment discontinuation: a retrospective cohort study using Canadian claims-level data.
Clin Rheumatol
; 37(9): 2351-2360, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29766376
18.
Patterns and predictors of long-term retention of inflammatory bowel or rheumatoid disease patients on innovator infliximab: an analysis of a Canadian prescriptions claims database.
Patient Prefer Adherence
; 12: 1805-1814, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30271124
19.
4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis.
RMD Open
; 4(1): e000582, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29556416
20.
Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #1.
J Rheumatol
; 50(9): 1198-1199, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37527865